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Leishmania spp. are protozoan parasites that are 
responsible for a spectrum of diseases in the   
human  host.  The  promastigote  form  of  the 
parasite is transmitted into the skin of a mam­
malian host when an infected sandfly takes a 
blood meal. Promastigotes are rapidly taken up 
by professional phagocytic cells, and transform 
into the intracellular amastigote form. Parasites 
reside and replicate within macrophage phago­
lysosomes impervious to the low pH and acid 
hydrolases of this environment. Although vir­
tually all phagocytic cells are capable of parasite 
phagocytosis, the macrophage appears to be   
the primary, if not exclusive, site for parasite 
replication. Successful host defense against this 
intracellular parasite involves the generation of 
antigen­specific T cells producing IFN­ (Afonso 
and Scott, 1993). This results in the generation 
of classically activated macrophages, which are 
defined by their ability to kill this and other 
intracellular pathogens (Mosser and Edwards 
2008; Yang et al., 2010).
Tissue macrophages can arise from one of 
two major sources. During steady state, resi­
dent tissue macrophages homeostatically arise 
from local tissue­resident progenitor stem cells, 
which repopulate mature tissue macrophages. 
During inflammation, however, monocytes 
from the blood represent the major source of 
macrophages. Monocytes rapidly exit the blood 
and transform into macrophages. In most local­
ized inflammatory events involving leukocyte 
migration from the blood, neutrophils are the 
first  cells  to  arrive,  followed  by  monocytes, 
which replace the short­lived neutrophils and 
persist in tissue as macrophages until the in­
flammation  subsides.  There  are  two  major   
subpopulations of monocytes, based on their 
morphology and physiology (Geissmann et al., 
2003;  Strauss­Ayali  et  al.,  2007).  These  two 
monocyte populations can be identified by   
differential surface marker expression. In the 
mouse, the two major monocyte subpopula­
tions  are  roughly  equally  represented  in  the 
blood. One of the populations expresses the 
granulocyte  marker  called  GR1,  which  in 
monocytes  and  macrophages  is  now  more 
commonly referred to as Ly6C. This subpopu­
lation also expresses relatively high levels of   
the CC­chemokine receptor 2 (CCR2), but 
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Leishmania species trigger a brisk inflammatory response and efficiently induce cell-mediated 
immunity. We examined the mechanisms whereby leukocytes were recruited into lesions 
after Leishmania major infection of mice. We found that a subpopulation of effector 
monocytes expressing the granulocyte marker GR1 (Ly6C) is rapidly recruited into lesions, 
and these monocytes efficiently kill L. major parasites. The recruitment of this subpopula-
tion of monocytes depends on the chemokine receptor CCR2 and the activation of plate-
lets. Activated platelets secrete platelet-derived growth factor, which induces the rapid 
release of CCL2 from leukocytes and mesenchymal cells. This work points to a new role for 
platelets in host defense involving the selective recruitment of a subpopulation of effector 
monocytes from the blood to efficiently kill this intracellular parasite.
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Beaulieu and Freedman, 2010), and platelets can cleave   
extracellular  matrix  components  to  produce  inflammatory 
cleavage products (de la Motte et al., 2009). One of the major 
secretory products from the ­granules of activated platelets 
is platelet­derived growth factor (PDGF). PDGF has growth­
promoting activity (Alberta et al., 1999; Andrae et al., 2008), 
but it is also a potent inducer of the chemotactic factor CCL2 
(MCP­1) from a variety of immune and nonimmune cells 
(Alberta et al., 1999).
In this work, we examined the migration of monocyte 
subsets in response to L. major infection. We demonstrate that 
a subset of monocytes expressing high levels of CCR2 and 
the granulocyte marker GR1 are rapidly recruited to sites of 
L. major infection where they efficiently kill L. major parasites. 
Here, we examine the mechanism of monocyte recruitment, 
and the cells and factors that are involved in this process.
RESULTS
The kinetics of monocyte recruitment
We examined monocyte recruitment into L. major lesions 
using  mice  originally  developed  by  Jung  and  Littman  in 
which the fractalkine receptor (CX3CR1) was replaced by 
GFP (Jung et al., 2000). These mice were crossed to C57BL/6 
mice to develop mice that were heterozygous for GFP, and 
therefore expressed a functional CX3CR1. Fig. 1 A shows a 
low magnification fluorescence photomicrograph of the two 
populations of blood monocytes from these mice. There are 
clearly two populations of cells that can be separated on the 
basis of fluorescence intensity. The GFPBRIGHT cells express 
low or undetectable levels of the granulocyte marker GR1, 
whereas the GFPLOW cells express high levels of GR1 (Fig. 1 B). 
In uninfected mice, these two monocyte populations are 
roughly equally represented in the blood (Fig. 1 B; Geissmann 
et al., 2003).
Because CX3CR1GFP mice express GFP only in mono­
cytes and some undefined subsets of NK cells (Jung et al., 
2000), we performed a flow cytometry analysis using these 
mice to examine monocyte subpopulations in the footpads 
during infection. The cells were isolated from the footpads 
and stained for F4/80 and CD11b to avoid NK cell contami­
nation during the analysis. As expected, we found low num­
bers of monocytes in the footpads of uninfected mice (Fig. 1 C, 
top). At 24 h after infection with L. major, however, there 
was a dramatic increase in the number of GFPLOW monocytes 
in the footpads of infected mice. The percentage increased 
from 5.33 to 16.4% within the first 24 h of infection (Fig. 1 C, 
bottom).  These  rapidly  migrating  monocytes  express  the 
granulocyte marker GR1 (Fig. 1 C, right). We performed a 
kinetic  analysis  of  monocyte  recruitment  into  leishmanial   
lesions using the GFP mice crossed onto a RAG/ back­
ground  where  50%  of  the  leukocytes  in  the  blood  are 
monocytes. By as early as 30 min and 1 h after infection, we 
began to observe GR1+ monocyte entry into infected foot­
pads (Fig. 1 D). By 2 h, there was a pronounced accumula­
tion of these monocytes at the site of infection. The rapid 
migration of these monocytes into lesions preceded even that 
moderate to low levels of the fractalkine receptor (CX3CR1; 
Palframan et al., 2001; Geissmann et al., 2003; Tsou et al., 
2007; Auffray et al., 2009). The other monocyte subpopula­
tion lacks the granulocyte marker (GR1) and CCR2, but ex­
presses  high  levels  of  the  fractalkine  receptor  (Palframan   
et al., 2001; Tsou et al., 2007). Jung et al. (2000) developed a 
mouse strain in which CX3CR1 was replaced with GFP, to 
allow the identification of the two major monocyte subpop­
ulations. The GR1 cells, which express high levels of the 
fractalkine receptor, are GFPBright, whereas the GR1+ cells, 
which express low levels of fractalkine receptor, are GFPDull. 
We used these and other mice to examine the kinetics of 
monocyte recruitment in response to L. major infection.
The recruitment of leukocytes to the site of Leishmania 
spp. infections has, until recently, been a relatively under­
studied area. There is ample historical evidence that mono­
nuclear  phagocytes  are  recruited  to  the  site  of  infection, 
where they harbor intracellular parasites (Conrad et al., 2007; 
León et al., 2007; Villadangos 2007; Ng et al., 2008). Recent 
studies indicate that neutrophils are also rapidly recruited to 
the site of Leishmania infections (Peters et al., 2008). This ef­
ficient recruitment of leukocytes by Leishmania spp. is in stark 
contrast to the inability of this parasite to directly activate   
innate immune responses. These eukaryotic parasites fail to   
express many of the molecular patterns expressed on pro­
karyotes that efficiently activate Toll­like receptors (TLRs). 
Consequently, in vitro these organisms enter macrophages 
via a quiescent mechanism that fails to result in NF­B acti­
vation  and  elicits  negligible  cytokine  production  (unpub­
lished data). This silent mechanism of entry into phagocytes 
in vitro is not consistent with the inflammatory nature of 
many leishmanial lesions. Therefore, we set out to under­
stand how these parasites were able to rapidly recruit leuko­
cytes from the blood to the site of infection.
Platelets have long been appreciated to play an important 
role in hemostasis by virtue of their ability to become acti­
vated in response to damage to the vascular endothelium. 
Activated platelets exude pseudopods, assume a stellate shape, 
and self­aggregate to form platelet plugs. These platelet plugs 
can contribute to cardiovascular diseases because of thrombus 
formation after atherosclerotic plaque rupture. After binding 
to activated endothelium, activated platelets have been shown 
to promote the recruitment of monocytes, which play an im­
portant role in atherogenesis by differentiating into macro­
phages and causing the local inflammation (van Gils et al., 
2009; Semple and Freedman, 2010). A role for platelets dur­
ing inflammation and immune responses has been recently 
described (von Hundelshausen and Weber, 2007). Platelets 
are rapidly deployed to sites of infection where they can 
modulate immune/inflammatory processes by secreting cyto­
kines, chemokines, and other inflammatory mediators (Smyth 
et al., 2009; Semple and Freedman 2010; Yeaman, 2010).   
A role for platelets during bacterial (Yeaman, 2010) and para­
sitic (van der Heyde et al., 2005) infections has recently been 
described. Platelets express TLRs that can bind to bacterial 
products and signal mediator secretion (Zhang et al., 2009; JEM Vol. 208, No. 6 
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of  sorted  F4/80  intermediate  cells  were  examined.  They 
showed the typical mononuclear cell morphology of mono­
cytes, and there were virtually no polymorphonuclear cells in 
this F4/80 intermediate population. At this early time after 
infection, several intact and partially degraded intracellular   
L. major parasites could be observed within monocytes at the 
light microscopic level (Fig. 2 C, arrows). The F4/80Low/Neg 
cells  had  the  typical  polymorphonuclear  morphology  of   
neutrophils. To our surprise, we were not able to detect any 
intracellular parasites within these neutrophils.
Monocyte killing of L. major
We took advantage of red fluorescent protein (RFP)­L. major 
parasites, which were developed by one of the authors 
(Kimblin et al., 2008), to quantify parasite numbers in peri­
toneal monocytes in situ shortly after infection. By 1 h after 
infection, there was a large increase in the number of RFP­
positive (infected) monocytes in the peritoneum (Fig. 3 A, 
middle), relative to uninfected controls (left). The majority of 
these infected cells stained positively for GR1. This is also 
shown in the histogram in Fig. 3 B, where at 1 h, the major­
ity of GR1+ monocytes are infected with RFP­L. major (top). 
By as early as 4 h after infection, however, we detected very 
few intact RFP­L. major in these monocytes. In Fig. 3 A, the 
double­positive population decreased from 41% (middle) to 
0.32% (right). This is confirmed in the histogram in Fig. 3 B 
(bottom), where at 1 h the majority of parasites are located in 
the GR1+ population of monocytes. At 4 h, only a small 
shoulder of RFP­positive monocytes expressing GR1 was 
visible. The GR1 monocytes, in contrast, show a lower 
percentage of infected cells at 1 h, designated by the small 
shoulder of RFP­positive cells (Fig. 3 B, top right profile), 
and this low level of infection remains essentially unchanged 
of PMNs, which were found in low numbers in lesions at   
30 min and 1 h, but began to show a substantial accumulation 
by 2 h (unpublished data). The decreased frequency at 4 h 
(Fig. 1 D) was caused by the accumulation of neutrophils. 
Thus, a population of monocytes expressing the granulocyte 
marker GR1 rapidly exits the blood and enters into lesions in 
response to L. major infection.
A similar kinetic analysis was performed after L. major  
infection in the peritoneum of mice, because this anatomical 
location allows for the convenient collection of large num­
bers of monocytes for subsequent analysis. We could readily 
identify three leukocyte populations in the peritoneum, based 
on forward and side scatter and CD11b and F4/80 expres­
sion. The identity of each population was confirmed by   
morphology after fluorescence­activated cell sorting. The 
F4/80­high cells were resident peritoneal macrophages, the 
F4/80­intermediate cells were newly migrated monocytes, 
and the F4/80­low/absent cells were neutrophils (Fig. 2 C).
We observed a rapid migration of monocytes into the 
peritoneum in response to intraperitoneal L. major infection. 
Monocytes began to accumulate within 30 min of L. major 
infection in both BALB/c and C57BL/6 mice (Fig. 2 A). 
Over the first hour, the percentage of monocytes, designated 
by the F4/80 intermediate quadrant, increased from 5.08 to 
20.8% in the BALB/c mouse and from 8.03 to 17% in the 
C57BL/6 mouse. This rapid migration of monocytes into the 
peritoneum preceded that of neutrophils, which did not ex­
hibit substantial accumulation until 2 h after infection in the 
BALB/c mouse and 1 h in the C57BL/6 mouse (Fig. 2 A). 
The majority of rapidly migrating monocytes in response to 
L. major infection expressed the GR1 marker (Fig. 2 B). To 
demonstrate that our gating was able to correctly distinguish be­
tween the various leukocyte populations, cytospin preparations 
Figure 1.  The identification of inflammatory 
monocytes during L. major infection. (A) Fluorescent 
microscopy of PBMC from uninfected CX3CR1GFP/+ 
RAG2/ transgenic mice showing GFPHigh (GR1) and 
GFPLow (GR1+) cells. (B) Flow cytometry analysis of blood 
monocytes (PBMC) from CX3CR1GFP/+ mice showing that 
GR1+ monocytes (top right histogram) are derived from 
the GFP low population of blood monocytes, whereas 
GR1 monocytes (bottom right histogram) are derived 
from the GFPHigh population of monocytes. (C) Flow 
cytometry analyses of cells from the footpads of  
CX3CR1GFP/+ mice before (top) and 24 h after (bottom) 
infection with 2 × 106 L. major. Cells were gated based 
on FSC x SSC profile eliminating dead cells and debris, 
using the F4/80+ antibody. The numbers represent the 
frequency of gated cells. This plot is representative of at 
least three experiments using five mice per group.  
(D) The frequency of GR1+ monocytes in infected foot-
pads at the designated times after infection. The num-
bers represent the mean of the frequency of gated cells 
taken from three experiments using three mice per 
group. Bar, 50 μm.1256 Leishmania, monocytes, and host defense | Goncalves et al.
subpopulation of monocytes bound avidly to L. major, and 
at 60 min the majority of monocytes had at least 1 parasite 
attached to it and many of these monocytes had several par­
asites associated with them (Fig. 4 A). These monocytes ap­
peared to rapidly kill L. major parasites, because by as early 
as 3 h after incubation, there were substantially fewer intact 
parasites associated with the GR1+ subpopulation of mono­
cytes. The majority of the monocytes no longer had para­
sites associated with them and only a small percentage of the 
after 4 h (Fig. 3 B, bottom right profile). The extent of RFP­
L. major associated with monocyte subpopulations from three 
pooled experiments are shown in Fig. 3 C. In all cases, the 
GR1+ monocytes isolated from the peritoneum at 1 h after 
infection contained the majority of RFP parasites, and these 
parasites were rapidly cleared by 4 h. Thus, GR1+ monocytes 
rapidly enter the peritoneum and associate with L. major  
parasites, and within 4 h the majority of these organisms are 
degraded and no longer visible within these cells.
To directly address parasite killing by monocytes, in vitro 
infections were undertaken, using purified monocyte sub­
populations from CX3CR1GFP/+RAG2/ mice obtained 
by fluorescence­activated cell sorting. Metacyclic L. major 
promastigotes were added to the two populations of mono­
cytes and the number of RFP­L. major per monocyte was 
determined at 60 min and at 3 h after infection. The GR1+ 
Figure 2.  Monocyte migration into the peritoneum in response to 
infection with L. major promastigotes. (A) Flow cytometry analysis 
showing the kinetics of leukocyte infiltration into the peritoneum after 
infection with 2 × 106 L. major parasites. Three distinct populations of 
cells, identified by gating on CD11b and F4/80 levels, are designated by 
boxed areas. (B) Histograms showing GR1 expression on the F4/80IntCD11b+ 
monocytes between 30 min and 4 h after peritoneal infection with 2 × 106 
L. major. (C) Cytospin analysis of F4/80Int monocytes and F4/80Neg neutro-
phils after 1 h of peritoneal infection of C57BL/6 mice. Cells were gated 
based on FSC x SSC profile, eliminating dead cells and debris. Arrows 
point to L. major parasites inside cells. The numbers represent the fre-
quency of gated cells from one experiment, and are representative of at 
least 4 experiments using a total of 40 mice. Bars, 10 μm.
Figure 3.  The rapid killing of L. major parasites by GR1+ mono-
cytes. (A) Flow cytometry profiles of monocytes gated on F4/80+CD11b+GR1+ 
monocytes at 1 and 3 h after infection with RFP-L. major. Uninfected 
(naive) cells show no RFP staining (left profile). (B) Histograms showing 
GR1+ monocytes (left) or GR1 monocytes (right) infected with RFP-L. major 
after 1 h (top) or 4 h (bottom) with 2 × 106 RFP-L. major. (C) The number 
of infected (RFP-positive) F4/80+CD11b+ GR1+ monocytes (circles) and 
GR1 monocytes (squares) after peritoneal infection with 2 × 106 L. major 
parasites. Cells were gated based on FSC x SSC profiles to eliminate dead 
cells and then separated using antibodies to F4/80 and CD11b. The num-
ber showed in dot plots represent the frequency of gated cells from one 
experiment and are representative of 3 independent experiments using a 
total of 18 mice. The numbers on the y axis represent the mean of the 
absolute numbers of infected monocytes, and the error bars are the SD 
from three independent experiments.JEM Vol. 208, No. 6 
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efficiently killed metacyclic L. major promastigotes, and by 3 d 
there  were  no  viable  parasites  in  the  cultures  (Fig.  4  C).   
In contrast, the GR1 population was less efficient at killing   
L. major parasites, and there remained a substantial number of 
viable parasites in these cultures (Fig. 4 C).
The monocyte respiratory burst
Despite the fact that we added an excess of parasites to the 
GR1+ monocyte cultures (a 5:1 ratio of parasites to mono­
cytes), all of the parasites in the culture were killed within 3 d. 
We therefore visually examined the parasites at earlier times 
after infection to look for early evidence of parasite killing. 
Incubation of parasites with GR1+ monocytes resulted in   
a rapid alteration in parasite morphology (Fig. 5 A) and a   
dramatic decrease in parasite mobility (Fig. 5, C and D and   
Video 1). Normal metacyclic promastigotes exhibit a slender 
monocytes had more than 1 intact parasite associated with 
them (Fig. 4 A).
The number of L. major parasites associated with mono­
cytes at 1 and 3 h was quantitated from three independent 
experiments (Fig. 4 B). After 1 h, there was an average of 1.6 
parasites associated with each GR1+ monocyte, and this num­
ber declined by approximately half by as little as 3 h. Parasite 
association with the GR1 population of monocytes was also 
examined  and  compared  with  the  GR1+  population. The 
GR1 monocytes bound fewer parasites at 1 h than did the 
GR1+ cells, and the number of parasites associated with these 
cells at 3 h was slightly increased relative to the number bound 
at 1 h (Fig. 4, A and B).
We also undertook long­term in vitro infection studies,   
in which metacyclic promastigotes were added to monocytes 
and incubated unwashed for 3 d. At this time, parasite viability 
was quantitated by limiting dilution. The GR1+ monocytes 
Figure 4.  The in vitro killing of L. major by GR1+ monocytes from 
wild-type mice. (A) GR1+ (left) and GR1 (right) monocytes were sorted 
from CX3CR1GFP/+ RAG2/ mice by GFP expression and incubated with 
10:1 ratio of metacyclic RFP-L. major in vitro. Fluorescence photomicro-
graphs of gently washed monolayers were taken after 1 h (top) or 3 h 
(bottom). (B) The total mean number of L. major parasites (n = 3) associ-
ated with GR1+ or GR1 monocytes after 1 or 3 h in vitro infection.  
(C) GR1+ and GR1 monocytes were sorted based on CX3CR1GFP expres-
sion and incubated with 5:1 ratio of L. major to monocytes in vitro.  
The cells were kept in culture for 3 d at 37°C without washing. After 3 d, 
parasite numbers were calculated by serial dilution assays. Data represent 
the mean ± SE of 3 independent experiments using a total of 40 mice. 
Bars, 50 μm.
Figure 5.  The in vitro killing of L. major parasites by GR1+ mono-
cytes from wild-type and from phox/ mice. (A) Phase-contrast  
microscopy taken on an inverted photomicroscope of sorted wild-type GR1+ 
monocytes showing altered morphology of unfixed metacyclic L. major 
promastigotes when cultivated with (A) or without (B) GR1+ monocytes 
for 1 h. (C and D) GR1+ monocytes were isolated from wild-type (WT) or 
gp91 phox/ mice and sorted by F4/80 and GR1 expression. Monocytes 
were incubated with 5:1 ratio of L. major to monocytes in vitro. At 3 h the 
movement of extracellular promastigotes was determined using ImageJ 
software to calculate the mean distance (C) and velocity (D) from 20 se-
lected parasites per culture. At least 30 mice were used in 2 independent 
experiments. (E) The in vitro production of ROS. The kinetics of ROS pro-
duction from sorted GR1+ and GR1 infected monocytes in the presence 
of H2DCFDA measured by fluorometry. Data are from three independent 
experiments. (F) Monocytes from WT or phox/ mice were cultivated 
with L. major for 3 d without washing, at which time parasite viability 
was determined by limiting dilution assay. Data are the mean ± SEM from 
three independent experiments involving at least 20 mice. Bars, 50 μm.1258 Leishmania, monocytes, and host defense | Goncalves et al.
attached before internalization. Monocytes with peripherally 
attached parasites made substantial amounts of superoxide and 
stained brightly with H2DCFDA (Fig. S1). Therefore, ample 
superoxide production by these monocytes occurred even 
before the parasites were internalized.
To further analyze the role of the monocyte respiratory 
burst in L. major killing, we performed in vitro killing assays 
using monocytes from gp91(phox)/ monocytes. gp91(phox) 
is an essential component of the membrane­bound oxidase   
of phagocytes that generates reactive oxygen species. Neither 
GR1+ nor GR1 monocytes from gp91 (phox) knockout 
mice were able to efficiently kill L. major parasites over the   
3­d culture period (Fig. 5 F). Although there were slightly 
fewer viable parasites associated with the GR1+ monocytes, 
both subpopulations of cells supported large numbers of viable   
L. major parasites, as determined by limiting dilution assay 
(Fig. 5 F). Furthermore, the dramatic alterations in parasite 
morphology and mobility that occurred with wild­type GR1+ 
monocytes  was  not  observed  in  parasites  cultivated  with 
GR1+  monocytes  deficient  in  the  respiratory  burst  (Fig.  5,   
C  and  D). These  parasites  retained  their  morphology  and 
moved rapidly in the culture medium (Video 3; for tracking 
of parasite movement, see Video 4).
Monocyte mobilization in response to platelet activation
We examined the mechanism of monocyte migration in   
response to L. major infection. Previous work of 
others  demonstrated  that  the  GR1+  monocyte 
subpopulation  expresses  high  levels  of  CCR2 
(Palframan et al., 2001; Geissmann et al., 2003). 
Therefore,  we  examined  monocyte  migration 
into the peritoneum in normal C57BL/6 mice 
morphology (Fig. 5 B) and move very rapidly in liquid cul­
ture. Even the extracellular parasites that were not attached to 
GR1+ monocytes stopped their movement and took on a 
rounded morphology that is frequently observed in dying 
parasites. Parasites associated with the GR1 subpopulation 
of monocytes, in contrast, did not exhibit this alteration in 
morphology and their movement did not slow (Video 2).
To examine the mechanism of killing, we measured the 
monocyte respiratory burst after the addition of metacyclic   
L. major promastigotes to monocytes in vitro. Superoxide pro­
duction by each subpopulation of monocytes was measured 
by chemiluminescence of H2DCFDA. The GR1+ subpopula­
tion of monocytes rapidly produced detectable amounts of 
superoxide in response to L. major infection. By 30 min, the 
signal was above background and by 60 min it was substan­
tially higher than that produced by the GR1 subpopulation 
of monocytes (Fig. 5 E). These cells continued to produce 
high levels of superoxide for the 180­min observation period 
(Fig. 5 E). The GR1 subpopulation also produced measur­
able amounts of superoxide in response to L. major infection. 
However the levels of superoxide production by these cells 
were substantially lower than the GR1+ subpopulation (Fig. 5 E). 
At the single­cell level, superoxide production from infected 
monocytes was visualized by H2DCFDA staining (Fig. S1). By 
60 min after the addition of metacyclic promastigotes, many 
of the monocytes had promastigotes that were peripherally 
Figure 6.  The role of CCR2 in the recruitment of GR1+ 
monocytes. (A) Flow cytometry histograms comparing the 
recruitment of F4/80+CD11b+GR1+ monocytes in CCR2/  
(gray profile) or wild-type (black profile) mice after 2-h infection 
with 2 × 106 L. major parasites. (B) Lesion size in CCR2/ 
(squares) and wild-type C57BL/6 (circles) mice after infection 
with 2 × 106 L. major parasites. (C) Flow cytometry profiles 
showing the recruitment of F4/80 intermediate, GR1+ mono-
cytes into the peritoneum of mice after infection with 2 × 106  
L. major promastigotes, before (top right) or after (bottom right) 
treatment with CD41 antibody to deplete platelets.  
(D) The number of GR1+ monocytes in the peritoneum after 
infection with 2 × 106 L. major promastigotes in untreated mice 
(circles) or mice treated with CD41 antibody to deplete plate-
lets (squares). (E) The mean frequency of GR1+ monocytes re-
cruited to footpads after L. major infection with or without prior 
depletion of platelets using CD41 antibody. At least three  
mice per group were used in three independent experiments.  
(F) In vivo killing of L. major parasites. C57BL/6 mice were de-
pleted of platelets with -CD41 or not and CCR2/ mice were 
infected with 106 metacyclic L. major promastigotes in the hind 
footpad. At different times, the footpads were collected and  
RT-PCR was performed to measure parasite levels, as described 
in experimental procedures. Data are representative of two 
independent experiments using at least three mice per group.JEM Vol. 208, No. 6 
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Platelet activation by parasites depends  
on complement activation
To determine the mechanism whereby L. major promastigotes 
activate platelets, we incubated L. major with platelets in the 
presence or absence of serum as a source of complement.   
We and many other groups have previously demonstrated 
that Leishmania spp. are efficient activators of complement 
(Mosser and Edelson 1987; Mosser et al., 1992). We used 
platelet aggregation as a well­established indicator of platelet 
activation. The co­incubation of platelets and L. major alone 
or  in  heat­inactivated  serum  had  essentially  no  effect  on 
platelets. The platelets remained round and did not associate 
with the parasites or each other (Video 5). However, the ad­
dition of nonimmune serum to platelets and L. major resulted 
in the rapid activation of platelets and the clustering of para­
sites and platelets together into large aggregates (Fig. 7,   
A and B). This activation of platelets did not occur in serum 
from mice deficient in the third component of complement, 
C3, indicating that the early components of complement   
activation were required for this effect (Fig. 7 B). C5­deficient 
serum fully supported platelet activation (Fig. 7 B). Platelet 
activation occurred very rapidly (Video 6), and by as early as 
5 min aggregates of platelets and parasites could be visualized. 
By 10 min, platelets were in large clumps associated with 
multiple L. major parasites (Fig. 7 B and Video 6).
In addition to platelet aggregation, another well­established 
indicator of platelet activation is the expression of P­selectin 
(CD62P) on the surface of activated platelets. We measured 
CD62P expression on platelets by flow cytometry. After a 
30­min incubation of L. major with platelets in the presence 
of nonimmune C5­deficient serum, a substantial percentage 
of platelets expressed CD62P on their surface and an increased 
expression of CD41 (Fig. 7 C). Thus, platelet activation is 
dependent on complement activation. To determine whether 
GR1+ monocyte recruitment was dependent on the activa­
tion of complement, we examined the number of monocytes 
migrating into the peritoneal cavity of mice deficient in the 
third component of complement, C3, and compared this to 
complement­sufficient mice. Mice lacking opsonic comple­
ment attracted substantially fewer monocytes into the perito­
neum in response to L. major infection, and of these monocytes 
a much smaller percentage of them were effector monocytes 
that express GR1+ on their surface (Fig. 7 D). Therefore, 
Leishmania spp. activate platelets via the activation of comple­
ment to recruit effector monocytes.
Several groups have reported that platelet activation re­
sults in the release of PDGF (Yeaman 2010; Fox 2001). We 
measured the release of PDGF after the co­incubation of 
platelets with L. major promastigotes (Fig. 8 A). The isolation 
of platelets from normal mouse serum resulted in a small de­
gree of PDGF release caused by the isolation procedure itself. 
However, the in vitro co­incubation of platelets with L. major 
and normal plasma resulted in a substantial increase in PDGF 
release (Fig. 8 A). PDGF is a potent inducer of CCL2 (MCP­1) 
release from several different cell types, including fibroblasts 
(Strieter et al., 1989), macrophages (Yoshimura et al., 1989), 
compared with mice lacking CCR2. Mice lacking CCR2 
showed a profound defect in the rapid migration of the GR1+ 
subpopulation of monocytes into the peritoneum in response 
to L. major infection (Fig. 6 A). The lack of “effector” mono­
cyte migration in response to the parasite suggested that these 
mice should be more susceptible to L. major infection. That is 
what had previously been reported (Sato et al., 2000) and 
what we observe in Fig. 6 B. Mice deficient in the migration 
of this population of monocytes developed larger lesions than 
wild­type mice (Fig. 6 B). Because both of these mice are on 
the  genetically  resistant  (C57BL/6)  background,  even  the 
CCR2­deficient mice were eventually able to mount appro­
priate adaptive immune responses, which began to promote 
the clearance of the parasite (Fig. 6 B, 8 wk). Thus, CCR2 is 
an  important  mechanism  in  the  recruitment  of  effector 
monocytes to limit early infections.
In measuring the migration of monocyte subsets into the 
peritoneum, we noticed the clustering of platelets around   
L. major. Because activated platelets can represent an im­
portant source of chemoattractants and mediators, we ex­
amined monocyte recruitment in C57BL/6 mice infected 
with L. major in the presence or absence of platelets. Mice 
were administered antibody to CD41 to deplete platelets. 
This treatment results in a transient depletion of 75–90% of 
platelets (Fig. S2). Platelet depletion with CD41 resulted   
in a dramatic decrease in GR1+ monocyte recruitment into 
the peritoneum in response to L. major infection (Fig. 6 C). 
After only 1 h of infection of normal mice with L. major, the 
number of GR1+ monocytes in the peritoneum increased 
from baseline to >42,000 (Fig. 6 D), whereas prior depletion 
of platelets resulted in an accumulation of <10,000 mono­
cytes over that time. In mice depleted of platelets, monocyte 
recruitment into the peritoneum does not approach wild­
type levels for >2 h (Fig. 6 D). We performed a similar analysis 
to examine the recruitment of GR1+ monocytes into the 
footpads of infected mice in the presence or absence of plate­
lets (Fig. S3). Prior depletion of platelets with antibody to 
CD41 virtually eliminated the migration of GR1+ monocytes 
into the footpads of infected mice in response to L. major  
infection (Fig. 6 E).
We examined the killing of L. major in the footpads of in­
fected mice that were administered antiplatelet antibodies.   
In untreated wild­type mice, the number of parasites in the 
foot rapidly declined over the first 2 h. There was an 80% re­
duction in parasite DNA by 1 h and a 95% reduction by 2 h 
(Fig. 6 F). In mice administered antibodies to platelets, how­
ever, the killing did not occur as rapidly, and by 2 h after in­
fection the amount of parasite DNA was reduced by <50% 
(Fig. 6 F). These differences in parasite killing persisted for the 
first 8 h. The delay in parasite killing in platelet­depleted mice 
is comparable to the delay in parasite killing that occurs in 
mice lacking CCR2 (Fig. 6 F). Thus, in the two groups of 
mice that are deficient in effector monocyte migration, there 
is a delay in parasite killing at the site of infection that is con­
sistent with a role for these monocytes in early parasite killing 
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and endothelial cells (Rollins et al., 1990). We measured the 
release of CCL2 (MCP­1) from mouse embryo fibroblasts 
(MEFs) after their incubation with L. major, platelets, and 
normal plasma. The combination of parasites, plasma, and 
platelets resulted in the release of substantial amounts of CCL2 
(MCP­1) from MEFs (Fig. 8 B). This release was caused by 
the activation of platelets because in the absence of platelets 
L. major alone induced substantially less CCL2 (MCP­1) from 
MEFs (Fig. 8 B). Furthermore, in the presence of antibody to 
the PDGF receptor, CCL2 (MCP­1) production was sub­
stantially reduced (Fig. S4).
We  next  examined  local  PDGF  and  CCL2  (MCP­1) 
production at the site of infection in the footpads of mice in­
fected with L. major. PDGF was rapidly produced in response 
to L. major infection (Fig. 8 C). PDGF production peaked by 
20–30 min and began to decline thereafter. PDGF is a potent 
inducer of CCL2 (MCP­1) production. Therefore, we ex­
amined CCL2 (MCP­1) production at the site of infection. 
CCL2 (MCP­1) was also rapidly produced in the foot in re­
sponse to L. major infection. CCL2 (MCP­1) levels peaked 
by 30 min and remained high for 60 min (Fig. 8 D). The de­
pletion of platelets with antibody to CD41 resulted in the 
decreased production of both PDGF (Fig. 8 C) and CCL2/
MCP­1 (Fig. 8 D) at the site of infection. Thus, platelet acti­
vation by L. major results in the production of PDGF by 
platelets, which induces the local release of CCL2 (MCP­1) 
to recruit a subpopulation of CCR2­positive monocytes into 
leishmanial lesions. These monocytes rapidly kill L. major.
DISCUSSION
This work describes the rapid mobilization of a monocyte 
subpopulation from the blood after infection with the intra­
cellular protozoan parasite, Leishmania major. These monocytes 
efficiently kill these parasites. There were several unexpected 
observations that emerged from this work. The first pertained 
to the mechanism whereby effector monocytes were mobi­
lized from the blood. Leishmania spp. are eukaryotic parasites 
that lack many of the pattern associated molecular patterns 
typically displayed on prokaryotes. Despite this apparent lack 
of TLR activation, these organisms efficiently recruit leuko­
cytes into the sites of infection. We show that this recruit­
ment  occurs  by  a  unique  mechanism  that  involves  the   
rapid activation of platelets. The phenomenon of Leishmania 
spp. parasites binding to cells in the blood was previously 
Figure 7.  Platelet activation by L. major parasites. (A) Fluorescence 
photomicroscopy showing RFP-L. major parasites and CFP-labeled plate-
lets that were incubated for 30 min in the presence of fresh nonimmune 
serum from C3/ mice (left) or C5/ mice (right). (B) 2 × 107 CFP- 
platelets were incubated with 106 parasites for 1–30 min in the presence 
of serum from mice lacking C3 (C3/; top) or C5 (C5/; bottom), and 
then observed by fluorescence microscopy. (C) CD62P expression on platelets 
activated by L. major and complement. Left profile, platelets alone with no 
antibody; middle profile, L. major promastigotes plus platelets but no  
serum, stained with CD41; right profile, L. major plus complement and 
platelets, stained with CD41. (D) Monocyte recruitment into the peritoneal 
cavity of wild-type C57BL/6 (top) or C3/ (bottom) mice after 4 h of infec-
tion with 2 × 107 L. major parasites. The CD11b+ F4/80Int population was 
analyzed for GR1 expression (right profiles). (E) The total number of GR1+ 
monocytes migrating into the peritoneal cavity of wild-type or C3/ mice 
after infection with L. major. The platelet activation experiments (A–C) were 
performed >5 times using at least 10 mice/experiment. The experiments 
using C3/ mice (D and E) mice were performed twice using 12 mice.JEM Vol. 208, No. 6 
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They demonstrated that this population of monocytes was 
recruited into the peritoneum independently of neutrophils. 
Auffray et al. (2007), however, demonstrated that the GR1 
monocyte subpopulation, which exhibits a patrolling behav­
ior in the blood, could rapidly immigrate to the site of infec­
tion with Listeria monocytogenes. This migration preceded that 
of GR1+ monocytes and neutrophils. In the present study, 
we describe the rapid migration of the GR1+ subpopulation 
of monocytes in response to L. major infection, and we dem­
onstrate that this migration is dependent on platelet activa­
tion and the elaboration of CCL2.
It has been appreciated for some time that monocytes 
could be separated into different subpopulations, based on 
their morphology and the expression of specific markers 
(Ziegler­Heitbrock et al., 1988; Passlick et al., 1989). It was 
not until the important work of Jung et al. (2000) that mono­
cyte  subpopulations  could  be  marked  with  GFP,  allowing 
them to be analyzed during homeostasis, inflammation, and 
infection. There appear to be a variety of distinct fates for 
these monocytes subsets after they leave the blood. Mono­
cytes expressing the GR1 marker have been shown to differ­
entiate into a population of dendritic cells that make large 
amounts of TNF (Serbina et al., 2003). They also appear to be 
capable of differentiating into macrophages with an alterna­
tively activated phenotype (Auffray et al., 2007) or even into 
microglia (Getts et al., 2008). Recent studies by other groups 
have begun to reveal an important role for these “effector” 
monocytes during infectious diseases, such as malaria (Sponaas   
et al., 2009). The production of type I interferon by these cells 
in  response  to  viral  infections  has  recently  been  reported 
(Barbalat et al., 2009). Consistent with our observations,   
Dunay et al. (2008) demonstrated that these cells are impor­
tant effector cells during Toxoplasma gondii infections. These 
cells have recently been shown to control the 
growth of YopM­negative Yersinia pestis (Ye et al., 
2009). The  direct  demonstration  that  these 
termed “immune adherence” (Domínguez and Toraño 2001). 
This phenomenon is dependent on the activation of comple­
ment,  and  more  than  two  decades  ago,  the  activation  of 
platelets by complement was shown to be mediated by plate­
let complement receptors (Fukuoka and Hugli 1988). Here, 
we demonstrate that complement activation by Leishmania 
spp. causes platelets to bind to L. major and release PDGF. 
Several  investigators  have  previously  demonstrated  that 
PDGF is an efficient inducer of CCL2 (MCP­1) production 
from a variety of cells, including endothelial and fibroblastoid 
cells and smooth muscles (Yoshimura and Leonard 1990; 
Poon et al., 1996; Deshmane et al., 2009). We demonstrate 
that PDGF production from activated platelets induces the 
release of CCL2 to recruit effector monocytes to the site of 
infection by virtue of their expression of CCR2 (Palframan 
et al., 2001; Geissmann et al., 2003). Thus, this work points 
to an unexpectedly specific role for platelets in early host de­
fense. The second unexpected aspect of this work was the 
speed with which these effector monocytes were dispatched 
to parasites. Dogma holds that PMNs are the first cells to   
enter inflammatory sites, but in this model a subpopulation of 
inflammatory  monocytes  accumulated  even  before  PMNs 
were mobilized. Recent work has shown that large amounts 
of neutrophils are attracted to the site of L. major infection   
after the bite of an infected sandfly (Peters et al., 2008). In 
those studies, neutrophils failed to kill intracellular L. major. 
In light of these observations, we would propose that the 
parasites would be efficiently killed in the presence of effector 
monocytes, whereas those parasites that enter resident tissue 
macrophages or perhaps neutrophils may escape monocyte 
killing and establish infection. The rapid recruitment of 
GR1+ monocytes in response to thioglycollate administra­
tion was previously reported by Henderson et al. (2003). 
Figure 8.  Chemotactic activity associated with the 
activation of platelets. (A) Platelets were isolated from 
normal mice and incubated with L. major promastigotes 
in the presence or absence of plasma as a source of com-
plement. The release of PDGF from activated platelets 
after 30-min incubation was measured by ELISA. (B) CCL2 
(MCP-1) production by MEF exposed to activated plate-
lets was measured by ELISA. MEFs were incubated in 
culture medium alone, medium containing L. major, or 
medium containing L. major and fresh plasma for 30 min. 
(C and D) Mice were injected in the footpad with 25 µl 
saline alone (filled triangles) or saline containing 2 × 106 
L. major parasites (filled circles). 24 h before infection 
some mice received 2 µg anti-CD41 antibody i.p. to de-
plete platelets (open circles). The production of PDGF (C) 
or CCL2/MCP-1 (D) was measured by ELISA and normal-
ized to the total protein. Data represent the mean ± SE of 
the mean, from 3 independent experiments using a total 
of 15 mice. Data on platelet depletion was performed on 
five mice.1262 Leishmania, monocytes, and host defense | Goncalves et al.
that the studies presented in this work may extend to many 
infections in which activated platelets mobilize monocytes 
and contribute to host defense.
MATERIALS AND METHODS
Mice. These studies were reviewed and approved by the University of Mary­
land Institutional Animal Care and Use Committee (IACUC). BALB/c and 
C57BL/6 mice were purchased from the National Cancer Institute Charles 
River Laboratories. Knockout mice rendered genetically deficient in com­
plement fragment C3 (C3/) or C5 (C5/), in the gp91 phagocyte oxi­
dase (phox/), and in the recombinase 2 enzyme (RAG2/) and transgenic 
mice expressing enhanced cyan­fluorescent protein C57BL/6 ECFP and green 
fluorescent protein driven by the fractalkine receptor CX3CR1GFP/GFP mice 
were purchased from The Jackson Laboratory. CX3CR1GFP/GFP mice were 
backcrossed with WT C57BL/6 mice to obtain cells expressing both GFP and 
CX3CR1 molecules (CX3CR1GFP/+)3. These mice were used for in vivo ex­
periments. The CX3CR1GFP/GFP mice were crossed with RAG2/ mice, as 
previously described (Geissmann et al., 2003), to obtain mice expressing high 
numbers of monocytes in their blood. In brief, CX3CR1GFP/GFP mice were 
crossed to RAG2/. Those homozygous mice (CX3CR1GFP/GFPRAG2/) 
were crossed back to RAG2/ to obtain a strain with high numbers of 
monocytes expressing GFP and a functional CX3CR1. These mice were used 
for in vitro experiments on purified monocytes.
Parasites.  L.  major  and  RFP­L.  major  (WHO  MHOM/IL/80/Friedlin) 
were isolated from infected BALB/c mice and grown as previously described 
(Conrad et al., 2007) In brief, parasites were grown in medium containing 
equal parts Schneider’s insect medium (Sigma­Aldrich) and M­199 (Invitrogen) 
supplemented with 20% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 
and 2 mM glutamine. RFP­L. major were developed by one of the authors 
(A. Debrabant) as previously described (Kimblin et al., 2008). Transgenic 
parasites were grown in the presence of 50 µg/ml of Geneticin (G418; Sigma­
Aldrich). Mice were injected in the left hind footpad with 2 × 106 L. major, 
and lesion size was determined by using a caliper to measure the thickness of 
the infected footpad and subtracting the thickness of the contralateral unin­
fected footpad as described previously (Rødland et al., 2010). RFP­L. major 
promastigotes were used for the peritoneal infection experiments. Metacyclic 
parasites were obtained as previously described (da Silva and Sacks, 1987) and 
used  for  all  killing  experiments.  In  brief,  stationary  phase  parasites  were 
washed three times with DPBS and resuspended in RPMI containing 50 µg/ml 
peanut agglutinin (Vector Laboratories Inc.) and incubated for 15 min at 
room temperature. Parasites were centrifuged at low speed (500 RPM) for   
10 min. The supernatant was collected and diluted with DPBS. The mixture 
was centrifuged at 3,500 RPM for 15 min to pellet metacyclic promastigotes.
MEFs. MEF were prepared following the protocol from Theo Ross at the 
University of Michigan from mouse fetuses harvested between day 12.5 and 
14.5 of gestation. Minced tissue pieces were incubated with 2 ml trypsin­
EDTA (Invitrogen) at 37°C for 10 min. After centrifugation at 350 g for   
10 min, the pellets were resuspended with DME containing 10% FBS and   
2 mM glutamine supplemented with 100 U/ml of penicillin and 100 µg/ml 
of streptomycin. The fetal tissue was vigorously pipetted to obtain a single 
cell suspension that was then incubated at 37°C. After three to five passages, 
the cells were used for experimentation as indicated in the figure legends.
Platelet isolation and depletion. Platelets from WT mice or from trans­
genic mice expressing an enhanced cyan fluorescent protein were isolated as 
previously described (Johnson et al., 1998) with the following minor modi­
fications. In brief, 500 µl of blood was collected by cardiac puncture into 100 µl 
of 3.8% sodium citrate. 400 µl of cation­free PBS was added and mixed gen­
tly with the platelets, which were then centrifuged at 90 g for 12 min.   
Supernatants were collected and centrifuged at 2,000 g for 3 min. The platelet 
pellet was suspended in cation­free PBS and the number of platelets was counted. 
To transiently deplete platelets from mice, we injected intraperitoneally 2 µg of 
monocytes are able to kill parasites had not been made, and 
the mechanisms whereby these cells are recruited from the 
blood into tissue had not been previously explored.
The present work on monocyte killing of L. major pro­
mastigotes  inadvertently  extends  observations  made  by  us 
20 yr ago that complement activation was important for 
the efficient phagocytosis of Leishmania spp. (Mosser et al., 
1992). We now show another mechanism whereby comple­
ment improves L. major clearance in nonimmune hosts. The 
activation of complement by Leishmania spp. results in the 
activation of platelets to recruit a monocyte subpopulation 
that can rapidly kill L. major. We examined the mechanisms 
responsible for the rapid killing of L. major parasites by the 
GR1+ monocytes. These effector monocytes produce high 
levels of superoxide when encountering L. major parasites, 
consistent with this being a mechanism that contributes to 
parasite killing. Monocytes that were unable to produce a re­
spiratory burst because of the lack of gp91(phox) were unable 
to kill L. major parasites. These monocytes also failed to in­
duce the profound changes in parasite morphology and mo­
bility that we observed. These data argue that superoxide is 
necessary for parasite killing, but they do not address whether 
oxygen radicals are sufficient to mediate L. major parasite   
killing. In several experimental systems, the accumulation of 
oxygen radicals has been associated with the induction of   
cellular apoptosis, and some groups have recently described   
programmed cell death in Leishmania species and other unicellu­
lar  organisms  that  results  from  oxidative  stress  (Duszenko   
et al., 2006; Kulkarni et al., 2009; Ye et al., 2009). Our ob­
servations pertaining to the rapid alterations in parasite mor­
phology after a brief cultivation with GR1+ monocytes 
would be consistent with an apoptotic mechanism of parasite 
death. The mechanisms by which GR1+ monocytes induce 
parasite death will be the subject of further studies.
Platelets have been shown to be very important in hemeo­
stasis and in the pathogenesis of cardiovascular disease. Now 
more attention is being given to their role in the pathogenesis 
of infectious diseases, including Malaria (Bruchhaus et al., 
2007), Aspergillosis (McMorran et al., 2009), and bacterial 
infections (Yeaman 2010). This role is attributed to their ca­
pacity to release cytokines and chemokines, mediating in­
flammation and immune responses. In the present study, we 
demonstrate that platelets can be activated by Leishmania spp. 
to recruit an important subset of effector monocytes that can 
influence the outcome of disease. In this regard, platelets can 
be considered one of the first cells to initiate innate immune 
responses to this organism. Platelets are likely to be present in 
high numbers at the site of infection in the pool of blood cre­
ated during the sandfly meal. The direct inhibition of platelet 
activation by sandfly saliva may be an important mechanism 
to limit effector monocyte recruitment during infection. Fur­
thermore, the inhibition of complement activation by sandfly 
saliva may also decrease the migration of these monocytes 
into lesions. The contribution of activated platelets to innate 
host defense will most likely extend to many other infectious 
organisms that activate complement. We therefore anticipate JEM Vol. 208, No. 6 
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To measure CCL2 and PDGF­BB in infected footpads, the feet were 
removed and strained through a 70­µm cell strainer, and washed with 500 µl 
of PBS. Tissue homogenates were centrifuged, and the supernatant was col­
lected for ELISA and expressed relative to total protein, which was deter­
mined by the Bradford assay.
ROS detection. To detect ROS production at the single cell level, the   
Image­iT LIVE Green Reactive Oxygen Species Detection kit (I36007; Invit­
rogen) was used following the manufacturer’s instructions. In brief, monocytes 
were washed twice with HBSS and incubated with 1:10 ratio of metacyclic   
L. major for 30 min. Next, prewarmed H2DCFDA was added to the cells for   
30 min at 37°C. The cells were incubated with Hoechst for the last 5 min to 
stain the nuclei of the cells. The cells were immediately analyzed by fluorescence 
microscopy. To quantitate ROS production at the population level, monocytes 
and L. major were co­cultivated at 37°C in HBSS containing 25 µM H2DCFDA. 
Measurements were made every 10 min by fluorometer for a total of 3 h.
Parasite burden quantitation. A qPCR method to amplify parasite DNA 
was used to quantify parasite burden (Yang et al., 2010). In brief, the infected 
footpads were collected at different times and treated with proteinase K 
(Sigma­Aldrich) at 56°C in the presence of 10 mM EDTA overnight. The 
DNA was obtained after phenol/chloroform extraction and NaOAC/EtOH 
precipitation. Primers specific for L. major 18S rRNA gene were as follows: 
5­ATCGGCATCATCAGCGGCGG­3 (sense) and 5­TCGACGGGT­
GGTGGCCAATGTGC­3 (antisense). PCR amplification of murine 18S 
rRNA gene was used as reference marker for normalization. The primers 
used were as follows: 5­CCCAGTAAGTGCGGGTCATA­3 (sense) and 
5­AGTTCGACCGTCTTCTCAGC­3 (antisense). qPCR was conducted 
with  the  LightCycler  480  sequence  detection  system  (Roche)  using  iQ 
SYBR Green Supermix (Bio­Rad Laboratories) following the manufacturer’s 
instructions. The parasite burden was expressed as fold changes by using the 
CT method, as previously described (Yang et al., 2007).
Online supplemental material. Fig. S1 shows ROS production by GR1+ 
monocytes. Fig. S2 shows the depletion of mouse platelets by intraperitoneal 
injection of ­CD41 antibody in vivo. Fig. S3 shows that CCL2 (MCP­1) 
production from MEFs was inhibited by blocking the PDGF receptor. Fig. 
S4 shows the recruitment of effector monocytes after L. major infection in 
the footpad after platelet depletion. In Video 1, GR1+ monocytes from WT 
mice were incubated with metacyclic L. major promastigotes for 1 h. In 
Video 2, GR1 monocytes from WT mice were incubated with metacyclic 
L. major promastigotes for 1 h. In Video 3, GR1+ monocytes from Phox/ 
mice were incubated with L. major parasites. In video 4, GR1+ monocytes 
from Phox/ mice were co­cultured with metacyclic L. major promasti­
gotes, and parasite movement was tracked. In video 5, the lack of platelet 
activation is shown after the incubation of platelets with L. major parasites in 
the presence of C3/ serum (lacking active complement). In video 6, plate­
let activation in the presence of C5/ serum containing opsonic comple­
ment and L. major parasites. Online supplemental material is a available at 
http://www.jem.org/cgi/content/full/jem.20101751/DC1.
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anti­CD41 (clone eBioMWReg30; eBioscience) diluted in 100 µl of PBS, 
18­24 h before initiating experiments.
Isolation of monocytes from blood and from footpads. To obtain 
monocytes from blood, mice were bled from the orbital plexus, and blood 
was collected in 3­mL vacutainer tubes with EDTA (BD). Blood was gently 
mixed with an equal volume of HBSS containing EDTA (0.3 mM) and iso­
lated  by  density  gradient  centrifugation  using  Histopaque  1083  (Sigma­ 
Aldrich) at 920 g at room temperature. Interface cells were collected and cells 
washed with DMEM and resuspended in PBS. The red blood cells were 
lysed using Pharm Lyse (BD) washed and resuspended in either staining buf­
fer or PBS, depending on the experiment.
To obtain monocytes from footpads, mice were infected with 2 × 106 
L. major in 10 µl saline in both footpads for the prescribed time, after which 
the footpads were excised. The skin was cut with scissors and the exposed 
tissue was placed in a 24­well plate containing 1.2 µg/ml of Liberase RI 
(Roche). The tissue was incubated for 1 h at 37°C, at which time the foot­
pads were forced through a 70­µm cell strainer (BD) and washed with PBS. 
The red blood cells were lysed using Pharm Lyse and washed, and the re­
maining cells were resuspended in staining buffer.
Flow cytometry. Freshly isolated peritoneal or peripheral blood leukocytes,   
or cells isolated from infected footpads, were stained with mAb specific for 
F4/80­PE and F4/80­PB (BioLegend), and CD11b­PE/Cy7, CD11b PE, 
RB6­8C5­Percp/Cy5.5 (Anti­GR1), and CD115 PE (BD). Cells were gated 
on forward and side scatter to exclude cell debris and dead cells, using an 
aqua  fluorescent  reactive  dye  (L34957;  Invitrogen)  or  propidium  iodide 
(P4170; Sigma­Aldrich). Data were collected using a FACSCanto II (BD) 
with Diva (BD) and analyzed with FlowJo (Tree Star) software. The GR1+ 
and GR1 monocytes were sorted based on CX3CR1GFP expression from 
CX3CR1GFP/+RAG2/  mice  or  stained  for  F4/80  PB  and  RB6­8C5 
Percp/Cy5.5 from RAG2/ mice and sorted using FACSAria II (BD Cell 
Sorter System; BD). Platelets were stained with antibody to CD41­FITC and 
CD62P­PE (eBioscience).
Microscopy and immunofluorescence. Monocytes were isolated from 
the blood or the peritoneum and cytospun onto glass slides for analysis of GFP 
expression (Fig. 1). For L. major killing assays, sorted GR1+ and GR1 mono­
cytes were seeded on coverslips and infected with a 5:1 ratio of RFP L. major 
to monocytes for 1 or 3 h in the presence of C5­deficient nonimmune serum. 
After brief washing with PBS, cells were fixed in methanol at 4°C for 15 min 
and then washed with PBS. For some studies, including those performed on 
monocytes from phox/ mice, parasites were added to monocytes at a   
5:1 ratio and cultivated unwashed for 3 d. At that time, viable parasite num­
bers were quantitated by limiting dilution assay, as previously described (Miles 
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